Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The history now shows a new revision v3.6.6 replacing v3.6.5, signaling a published update to the page's version.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:32.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new version (65) was added to the study history on 2026-08-19/20, updating the Study Status and Contacts/Locations sections; the version dated 2026-05-28 was removed from the history.
    Difference
    0.2%
    Check dated 2026-08-24T17:22:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s revision label changed from v3.6.4 to v3.6.5, signaling a software update to the page without altering study data.
    Difference
    0.0%
    Check dated 2026-08-10T11:23:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page shows a site revision update from v3.6.3 to v3.6.4, signaling a site-wide update. This change does not alter the content of the trial record or its history entries.
    Difference
    0.0%
    Check dated 2026-07-27T06:29:06.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed in the history. This represents a versioning update to the page history rather than a modification to trial data or core content.
    Difference
    0.0%
    Check dated 2026-07-05T14:30:31.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a software update to the ClinicalTrials.gov interface and does not modify the study history data.
    Difference
    0.0%
    Check dated 2026-06-28T08:39:29.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.